Lyka Labs (BOM:500259) EV-to-Revenue : 4.34 (As of May. 28, 2024)

View and export this data going back to 1992. Start your Free Trial

What is Lyka Labs EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Lyka Labs's enterprise value is ₹4,383 Mil. Lyka Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was ₹1,009 Mil. Therefore, Lyka Labs's EV-to-Revenue for today is 4.34.

The historical rank and industry rank for Lyka Labs's EV-to-Revenue or its related term are showing as below:

BOM:500259' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.16 Med: 1.79 Max: 5.76
Current: 4.34

During the past 13 years, the highest EV-to-Revenue of Lyka Labs was 5.76. The lowest was 0.16. And the median was 1.79.

BOM:500259's EV-to-Revenue is ranked better than
65.03% of 1038 companies
in the Biotechnology industry
Industry Median: 8.115 vs BOM:500259: 4.34

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-28), Lyka Labs's stock price is ₹109.00. Lyka Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was ₹31.82. Therefore, Lyka Labs's PS Ratio for today is 3.43.

Lyka Labs EV-to-Revenue Historical Data

The historical data trend for Lyka Labs's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lyka Labs EV-to-Revenue Chart

Lyka Labs Annual Data

Trend

Mar13

Jun14

Jun15

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

EV-to-Revenue

Get a 7-Day Free Trial

2.55

3.18

3.48

2.81

4.42

Lyka Labs Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															3.89	4.42	4.43	5.00	4.08

Competitive Comparison of Lyka Labs's EV-to-Revenue

For the Biotechnology subindustry, Lyka Labs's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lyka Labs's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Lyka Labs's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Lyka Labs's EV-to-Revenue falls into.

Lyka Labs EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Lyka Labs's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	4382.934	/	1009.321
	=	4.34

Lyka Labs's current Enterprise Value is ₹4,383 Mil.
Lyka Labs's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,009 Mil.

Lyka Labs (BOM:500259) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Lyka Labs's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	109.00	/	31.817
	=	3.43

Lyka Labs's share price for today is ₹109.00.
Lyka Labs's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹31.82.

Lyka Labs EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lyka Labs's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lyka Labs (BOM:500259) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Lyka Labs Ltd (BOM:500259) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

LYKALABS:India

Address

30, Forjett Street, Near Bhatia Hospital, Ground floor, Spencer Building (Block B & C), Grant Road (West), Mumbai, MH, IND, 400036

Website

http://www.lykalabs.com

Lyka Labs Ltd is an Indian biotechnology company. It mainly engages in the development of specialized formulations. The Company is engaged in only one segment viz. pharmaceuticals. The Company has presence in Domestic as well as International markets. The commercialized formulations of the company consist of hair care, anti-aging, acne management, skin lightening, face washes, sunscreens, facial scrubs, and others. It has developed a varied drug delivery system for topical steroids, painkillers, anti-fungal, and other emollients as well as liquid injectables, lyophilized injectables in the anti-bacterial, antifungal segment. The company also manufactures proton pump inhibitors, antibiotics, antifungals, steroids, etc. The majority of the company's revenue comes from India.

Lyka Labs (BOM:500259) Headlines

No Headlines